Application US20200330378

TASTE-ENHANCED CANNABINOID SUBMICRON EMULSION SYRUP COMPOSITIONS
[+] Show Details

US20200330378

1. A stable oil-in-water submicron emulsion oral cannabinoid composition, comprising from about 0.05% w/w to about 10% w/w of at least one cannabinoid in a pharmaceutically acceptable carrier, from about 1% w/w to about 10% w/w of at least one triglyceride oil, from about 1% w/w to about 10% w/w of at least two emulsifiers, of which one having an HLB value from about 10 to about 16 and the other(s) having an HLB from about 2 to about 8, from about 1% w/w to about 40% w/w of at least one taste-enhancing excipient and from about 1% w/w to about 60% w/w of water, (16) (4)

wherein the composition is essentially free of bitter taste, and

wherein the ratio between the at least one cannabinoid and the at least two emulsifiers is at least 1:5, and

wherein the emulsion oil phase comprises not more than 10% by weight of the composition and

wherein the composition is essentially free of phospholipids, liposomes and/or micelles.

2. The composition of claim 1, wherein the emulsion is stable at ambient temperature for at least 12-24 months and does not separate or cream under accelerated conditions. (0)

3. The composition of claim 1, wherein the at least one taste-enhancing excipient is selected from sucrose, glucose, sucralose, glycerin, aspartame, cyclamate, stevia, erythritol, xylitol, acesulfam, honey, sucrose syrup, maple syrup, raspberry syrup, glycyrrhizin, glycyrrhitinic acid, glycyrrhizinate salts, Glycyrrhiza glabra extracts and combinations thereof. (1) (0)

5. The composition of claim 1, wherein the at least one cannabinoid is at a high strength, and wherein a teaspoon of the syrup composition comprises at least 100 mg, at least 200 mg or at least 500 mg of a cannabinoid. (0)

6. The composition of claim 1, wherein the ratio by weight of the at least one cannabinoid and the ratio of the at least one triglyceride oil to the at least two emulsifiers is from 1:2 to about 10:1 and wherein the total cannabinoids amount by weight is above its solubility in the oil (0)

7. The composition of claim 1, wherein the at least one cannabinoid is selected from the group consisting of a natural or synthetic cannabinoid or cannabinoid combination: selected from the group consisting of cannabidiol (CBD), cannabidiolic acid (CBDA), tetrahydrocannabinol (THC), tetrahydrocannabinolic acid (THCA), cannabigerol (CBG), cannabichromene (CBC), cannabinol (CBN), cannabielsoin (CBE), iso-tetrahydrocannabimol (iso-THC), cannabicyclol (CBL), cannabicitran (CBT), cannabivarin (CBV), tetrahydrocannabivarin (THCV), cannabidivarin (CBDV), cannabichromevarin (CBCV), cannabigerovarin (CBGV), cannabigerol monomethyl ether (CBGM), salts thereof, derivatives thereof, cannabis oil, cannabis extract and combinations thereof. (0)

8. The composition of claim 1, wherein the at least one triglyceride oil is selected from the group consisting of vegetable oil, corn oil, peppermint oil, canola oil, poppy seed oil, palm oil, soybean oil, hydrogenated soybean oil, sesame oil, rapeseed oil, sunflower seed oil, peanut oil, castor oil, hydrogenated castor oil, cottonseed oil, palm kernel oil, coconut oil, olive oil, borage oil and combinations thereof. (0)

9. The composition of claim 1, wherein at least one of the at least two emulsifiers having a HLB value of from about 10 to about 16 is selected from the group consisting of sucrose ester, sucrose fatty acid esters, sucrose stearate, sucrose distearate, sucrose palmitate, sucrose laurate, sucrose polystearate, polysorbate, polysorbate 80, oleoyl polyoxyl glycerides, polyoxyl hydrogenated castor oil, tocopherol polyethylene glycol 1000 succinate, polyoxyl glycerides, polyglyceryl fatty acid ester, and polymeric emulsifier Acrylates/C 10-30 Alkyl Acrylate Cross-Polymer and combinations thereof. (0)

10. The composition of claim 1, wherein the at least one emulsifier having HLB from about 2 to about 8 is selected from the group consisting of sorbitan fatty acid esters, sorbitan monooleate, sorbitan stearate, sorbitan oleate, sucrose ester, sucrose di and tri stearate, polyglyceryl fatty acid esters, polyglyceryl-3 dioleate, fatty acids esters and ethers, steareat-2, oleth-2, ceteth-2, salts thereof, derivatives thereof, and combinations thereof. (0)

11. The composition of claim 1, wherein the at least one cannabinoid exhibits an improved oral bioavailability at least about 100% higher than the oral bioavailability of same cannabinoid, when dissolved in an organic solvent or a mixture of organic solvents. (0)

12. The composition of claim 1, wherein the ratio between the at least one cannabinoid and the at least two emulsifiers is from about 1:4 to 10:1, from about 1:2 to about 5:1 or from about 1:1 to about 3:1. (0)

13. The composition of claim 1, wherein further comprising from about 0.1% w/w to about 5% w/w of at least one stabilizing or suspending agent. (0)

14. A dosage form comprising the composition of claim 1, wherein said dosage form is selected from an emulsion, a syrup, a liquid, a pudding, a gel and wherein administered with a spoon, a dropper or other volume measuring device or mixed with nutrients or foods. (0)

15. A kit for the treatment of geriatric syndrome and improvement of elderly and neurological patient's wellbeing, epilepsy, PTSD, anxiety, schizophrenia, Parkinson disease and autoimmune diseases that are also suffering from insomnia and improvement of their wellbeing comprising a day composition and a night composition according to claim 1, comprising a day composition comprising a. at least about 10 mg cannabis extract or at least one cannabinoid or derivatives thereof having a CBD:THC ratio of about 10 to about 200 and b. at least about 1 mg of at least one alerting terpene. (0) (1)

16. A method of treatment for inducing an alerting response by administration to a mammal subject in need thereof of a therapeutically effective amount of the composition of claim 1, wherein said composition comprising at least one cannabinoid selected from at least about 1 mg of cannabidiol, a derivative thereof and combinations thereof and at least about 1 mg of at least one alerting terpene per one serving. (1) (0)

18. A method of treatment for sedation and/or sleep inducing in a mammal in need thereof, by administration at about one hour before retiring to sleep or as needed of a therapeutically effective amount of the composition of claim 1, wherein comprising from about 1 mg to about 10 mg of at least one sedating cannabinoid and from about 0.5 mg to about 5 mg of at least one sedating terpene per unit serving. (1) (0)

20. The composition of claim 1 wherein the at least one cannabinoid is CBD. (0)

View Abstract and Specification Size

PDF with Images and Document Face >

Full Text Publication >

Application US20200330378

TASTE-ENHANCED CANNABINOID SUBMICRON EMULSION SYRUP COMPOSITIONS

Patent Matrix® Search